In a surprising turn of events, the FDA has allowed Sarepta Therapeutics to resume shipments of its gene therapy, Elevidys, for younger Duchenne muscular dystrophy patients who can walk, despite concerns over previous fatalities.
The US and EU have struck a trade deal aimed at avoiding a damaging trade war, but critics argue it heavily favors Trump’s policies. Will this accord truly stabilize relations or deepen the divide?
As the humanitarian crisis in Gaza deepens, Amjad Al Shawa reveals his family's struggle for basic necessities. With soaring food prices and collapsing infrastructure, he fears for thousands facing starvation. Can aid reach those in need?
Rumors around the iPhone 17 Pro suggest it may feature an 8x optical zoom camera, a new Pro camera app, and a second camera control button. Could this be a game changer for mobile photography?
A groundbreaking study reveals that human aging accelerates significantly around age 50, particularly affecting organ function and increasing chronic disease risk. Discover the science behind this pivotal point in life!
Hidden in the eastern California mountains, the Methuselah Tree, a nearly 5,000-year-old Great Basin Bristlecone Pine, stands as a testament to nature's endurance. Explore its secrets and the breathtaking trails of Inyo National Forest!
Leaders from Germany and France express deep concerns over the recent EU-US trade deal, warning it may harm their economies. Despite gloomy reactions, the agreement aims to avert a trade war. Is this a win or a loss for Europe?
In a dramatic shift, Trump gives Putin just 10 days to halt the violence in Ukraine, amid ongoing Russian drone attacks. Will this ultimatum lead to peace or escalation?
In a recent press conference, President Trump addressed his past relationship with Jeffrey Epstein, vehemently denying any wrongdoing and claiming he cut ties after an 'inappropriate' dispute. His remarks come amid ongoing scrutiny over Epstein's legacy and political implications.
The EU's ambitious framework agreement to import $250 billion in energy from the U.S. raises eyebrows. Experts question the feasibility of such targets, echoing past trade deal failures.
